Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 4281 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Teva and Lundbeck market Azilect in UK

The once-daily treatment can be used for Parkinson’s disease (PD) both as monotherapy in patients with early PD and as an adjunct treatment in moderate to advanced disease.

Clinigene and Scirex form research collaboration

The new relationship is designed to provide Scirex with immediate access to well developed expertise in clinical investigation in India whilst giving Clinigene the opportunity to expand its